Statins reduce the risk of liver decompensation and death in chronic viral hepatitis: a propensity score weighted landmark analysis.
J C-T WongHenry Lik Yuen ChanY-K TseT C-F YipVincent Wai-Sun WongGrace Lai-Hung WongPublished in: Alimentary pharmacology & therapeutics (2017)
Patients with chronic viral hepatitis who used statins have a reduced risk of liver decompensation and death compared to non-users in this propensity score weighted landmark analysis.